Written by Klarity Editorial Team
Published: May 19, 2026

Last updated: July 8, 2026
UnitedHealthcare plans in Florida may cover weight loss treatment — including GLP-1 medications such as Wegovy and Zepbound, obesity counseling, and medical nutrition therapy — under your medical or pharmacy benefits. Coverage depends on your specific plan, formulary tier, prior authorization requirements, and documentation of medical necessity. Florida state law and federal parity rules may strengthen your access to coverage. Klarity Health connects patients in Florida with 2,000+ licensed providers for online weight loss treatment and GLP-1 medication management.
Check if your UnitedHealthcare plan may cover weight loss treatment at Klarity →
Several Florida statutes and federal laws may be relevant when seeking coverage for weight loss treatment under a UnitedHealthcare plan:
UnitedHealthcare offers several plan types in Florida, each with different network and coverage structures:
OptumRx is UnitedHealthcare’s pharmacy benefit manager (PBM) for most Florida commercial plans and manages the formulary for prescription weight loss medications. Verify your specific plan’s formulary at optumrx.com or by calling the number on your insurance card, or contact UnitedHealthcare at 1-866-892-4053.
GLP-1 receptor agonists approved for chronic weight management are among the most effective medical weight loss treatments available. Coverage under UnitedHealthcare OptumRx plans in Florida varies by medication:
| Medication | Brand | Formulary Tier | Prior Authorization | Notes |
|---|---|---|---|---|
| Semaglutide (weight loss) | Wegovy | Tier 3–4 | Yes — BMI ≥30, or ≥27 with comorbidity | FDA-approved for chronic weight management |
| Tirzepatide (weight loss) | Zepbound | Tier 3–4 | Yes — BMI ≥30, or ≥27 with comorbidity | FDA-approved for chronic weight management (2023) |
| Liraglutide (weight loss) | Saxenda | Tier 3–4 | Yes — PA + step therapy | Step therapy may require prior behavioral or pharmacotherapy documentation |
| Semaglutide (diabetes) | Ozempic | Tier 3 | Yes | FDA-approved for Type 2 diabetes only — NOT approved for weight loss on most formularies. Using for weight management is off-label and typically not covered for this indication. |
| Tirzepatide (diabetes) | Mounjaro | Tier 3 | Yes | FDA-approved for Type 2 diabetes only — NOT approved for weight loss on most formularies. Using for weight management is off-label and typically not covered for this indication. |
Note: Ozempic and Mounjaro contain the same active ingredients as Wegovy and Zepbound, respectively, but are FDA-approved for different indications. Most UnitedHealthcare OptumRx plans in Florida cover these for diabetes only. For weight management specifically, Wegovy or Zepbound are the appropriate covered alternatives, subject to prior authorization. Coverage varies; verify with OptumRx before prescribing or filling.
Several non-GLP-1 oral medications may be covered for weight loss under UnitedHealthcare OptumRx plans in Florida:
| Medication | Brand | Schedule | Formulary Tier | Prior Auth | Notes |
|---|---|---|---|---|---|
| Phentermine (generic) | Adipex-P | Schedule IV — NOT Schedule II | Tier 1–2 | No PA typically | No EPCS required in Florida (§ 456.44 applies to Schedule II only). Short-term use indicated; often used as bridge while awaiting GLP-1 PA approval. |
| Phentermine/topiramate ER | Qsymia | Schedule IV — NOT Schedule II | Tier 3 | Yes — PA + REMS program | REMS enrollment required. No EPCS required for phentermine component (Schedule IV). |
| Naltrexone/bupropion ER | Contrave | Non-scheduled | Tier 3 | Yes — PA + step therapy | Step therapy may require prior behavioral or pharmacotherapy trial documentation. |
| Orlistat | Xenical / Alli (OTC) | Non-scheduled | Tier 1–2 | No | OTC version (Alli) not covered. Prescription Xenical may be covered on some plans. |
| Bupropion (off-label) | Wellbutrin | Non-scheduled | Tier 1–2 | Varies | Used off-label for weight management. Coverage as a weight loss treatment varies by plan. |
Florida Statute § 456.44 requires Electronic Prescribing for Controlled Substances (EPCS) for Schedule II medications only. Phentermine (including the combination product Qsymia) is classified as a Schedule IV controlled substance. This means:
UnitedHealthcare offers High Deductible Health Plans (HDHPs) in Florida that may be paired with a Health Savings Account (HSA). Key considerations for weight loss coverage:
Florida has not expanded Medicaid under the ACA. Florida Medicaid generally does not cover GLP-1 medications for weight management purposes, though coverage may exist for patients with Type 2 diabetes where the diabetes indication is documented. Patients who fall into the Medicaid coverage gap — income too high for traditional Medicaid but potentially ineligible for full ACA marketplace subsidies — may not have access to subsidized weight loss coverage. Cash-pay options for GLP-1 medications are available through Klarity. Contact Klarity Health for current cash-pay pricing.
If your UnitedHealthcare plan does not cover GLP-1 medications, manufacturer patient assistance programs may help reduce out-of-pocket costs:
See if your UnitedHealthcare plan may cover weight loss treatment at Klarity →
UnitedHealthcare plans in Florida may cover weight loss treatment including obesity counseling, medical nutrition therapy, and prescription medications under your medical or pharmacy benefits. Coverage depends on your specific plan, formulary, and prior authorization requirements. Verify your benefits with UnitedHealthcare or through Klarity’s benefits check before booking.
Some UnitedHealthcare OptumRx plans in Florida may cover Wegovy (semaglutide) or Zepbound (tirzepatide) for chronic weight management, subject to prior authorization and BMI criteria — typically BMI ≥30, or ≥27 with a weight-related comorbidity. Coverage is not guaranteed and varies by plan. Review your plan’s OptumRx formulary at optumrx.com or call 1-866-892-4053.
Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for Type 2 diabetes, not for weight loss. Most UnitedHealthcare OptumRx plans in Florida cover these medications for diabetic patients only. For weight management, Wegovy or Zepbound are the appropriate formulary alternatives, subject to prior authorization. Coverage varies; verify with OptumRx before filling.
Florida does not have a statute specifically mandating coverage for GLP-1 weight loss medications. However, Florida’s mental health parity laws (§ 627.6574 and § 627.6578) may support coverage of Binge Eating Disorder treatment — a DSM-5-recognized condition with high obesity comorbidity. ACA Section 2713 requires most non-grandfathered plans to cover preventive obesity counseling and intensive behavioral therapy at no cost-sharing. Coverage outcomes vary by plan; verify your specific benefits.
Phentermine is a Schedule IV controlled substance, not Schedule II. Florida Statute § 456.44 requires Electronic Prescribing for Controlled Substances (EPCS) for Schedule II medications only. As a result, Klarity providers in Florida do not need to use EPCS when prescribing phentermine or Qsymia. This is different from ADHD stimulants (Adderall, Vyvanse), which are Schedule II and require EPCS.
OptumRx is UnitedHealthcare’s pharmacy benefit manager (PBM) and manages prescription drug coverage for most UnitedHealthcare commercial plans in Florida. OptumRx determines which weight loss medications are on the formulary, their tier placement, and prior authorization criteria. To check your specific formulary, visit optumrx.com or call UnitedHealthcare at 1-866-892-4053.
Generally yes. Prescription weight loss medications and medically supervised obesity treatment are typically HSA-eligible expenses under IRS guidelines. If you have a UnitedHealthcare HDHP plan with an HSA, you can use HSA funds to pay copays, deductibles, and prescription costs for medically documented weight loss treatment. Preventive obesity counseling covered under ACA Section 2713 may be available before your HDHP deductible.
If UnitedHealthcare denies coverage, you have the right to appeal. Request a formal Explanation of Benefits (EOB) stating the denial reason, then submit a clinical appeal with supporting documentation from your Klarity provider, including BMI, comorbidities, and prior treatment history. If the internal appeal is denied, you may request an independent external review. For insurance compliance questions in Florida, contact the Florida Office of Insurance Regulation at 1-877-693-5236.
Disclaimer: Insurance coverage varies by plan, insurer, and state. The information on this page is intended as general guidance only and does not constitute a guarantee of benefits. Klarity Health is independent from UnitedHealthcare and OptumRx. Telehealth provider availability may vary by state. Please verify your specific plan’s coverage with your insurer or through Klarity’s benefits check before booking.
Check if your UnitedHealthcare plan may cover weight loss treatment in Florida →
Find the right provider for your needs — select your state to find expert care near you.